Impact of Pharmaceuticals on the Individual Wastewater Treatment System

Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as wel...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Małgorzata Helena Makowska [verfasserIn] Marcin Spychała [verfasserIn] Katarzyna Gajewska [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2024

Schlagwörter:	wastewater treatment small treatment plants activated sludge pharmaceuticals

Übergeordnetes Werk:	In: Journal of Ecological Engineering - Polish Society of Ecological Engineering (PTIE), 2014, 25(2024), 2, Seite 257-266
Übergeordnetes Werk:	volume:25 ; year:2024 ; number:2 ; pages:257-266

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.12911/22998993/176945

Katalog-ID:	DOAJ097958417

Internformat


LEADER	01000naa a22002652 4500
001	DOAJ097958417
003	DE-627
005	20240413201556.0
007	cr uuu---uuuuu
008	240413s2024 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.12911/22998993/176945 \|2 doi
035			\|a (DE-627)DOAJ097958417
035			\|a (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a TD1-1066
050		0	\|a GE1-350
100	0		\|a Małgorzata Helena Makowska \|e verfasserin \|4 aut
245	1	0	\|a Impact of Pharmaceuticals on the Individual Wastewater Treatment System
264		1	\|c 2024
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.
650		4	\|a wastewater treatment
650		4	\|a small treatment plants
650		4	\|a activated sludge
650		4	\|a pharmaceuticals
653		0	\|a Environmental technology. Sanitary engineering
653		0	\|a Environmental sciences
700	0		\|a Marcin Spychała \|e verfasserin \|4 aut
700	0		\|a Katarzyna Gajewska \|e verfasserin \|4 aut
773	0	8	\|i In \|t Journal of Ecological Engineering \|d Polish Society of Ecological Engineering (PTIE), 2014 \|g 25(2024), 2, Seite 257-266 \|w (DE-627)822335905 \|w (DE-600)2818368-X \|x 22998993 \|7 nnns
773	1	8	\|g volume:25 \|g year:2024 \|g number:2 \|g pages:257-266
856	4	0	\|u https://doi.org/10.12911/22998993/176945 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 \|z kostenfrei
856	4	0	\|u http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2299-8993 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 25 \|j 2024 \|e 2 \|h 257-266

Indexfelder

author_variant	m h m mhm m s ms k g kg
matchkey_str	article:22998993:2024----::matfhraetcloteniiulatw
hierarchy_sort_str	2024
callnumber-subject-code	TD
publishDate	2024
allfields	10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266
spelling	10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266
allfields_unstemmed	10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266
allfieldsGer	10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266
allfieldsSound	10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266
language	English
source	In Journal of Ecological Engineering 25(2024), 2, Seite 257-266 volume:25 year:2024 number:2 pages:257-266
sourceStr	In Journal of Ecological Engineering 25(2024), 2, Seite 257-266 volume:25 year:2024 number:2 pages:257-266
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences
isfreeaccess_bool	true
container_title	Journal of Ecological Engineering
authorswithroles_txt_mv	Małgorzata Helena Makowska @@aut@@ Marcin Spychała @@aut@@ Katarzyna Gajewska @@aut@@
publishDateDaySort_date	2024-01-01T00:00:00Z
hierarchy_top_id	822335905
id	DOAJ097958417
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ097958417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413201556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.12911/22998993/176945</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ097958417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TD1-1066</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">GE1-350</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Małgorzata Helena Makowska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of Pharmaceuticals on the Individual Wastewater Treatment System</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">wastewater treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">small treatment plants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">activated sludge</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pharmaceuticals</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental technology. Sanitary engineering</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental sciences</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marcin Spychała</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katarzyna Gajewska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Ecological Engineering</subfield><subfield code="d">Polish Society of Ecological Engineering (PTIE), 2014</subfield><subfield code="g">25(2024), 2, Seite 257-266</subfield><subfield code="w">(DE-627)822335905</subfield><subfield code="w">(DE-600)2818368-X</subfield><subfield code="x">22998993</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:257-266</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.12911/22998993/176945</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2299-8993</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2024</subfield><subfield code="e">2</subfield><subfield code="h">257-266</subfield></datafield></record></collection>
callnumber-first	T - Technology
author	Małgorzata Helena Makowska
spellingShingle	Małgorzata Helena Makowska misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences Impact of Pharmaceuticals on the Individual Wastewater Treatment System
authorStr	Małgorzata Helena Makowska
ppnlink_with_tag_str_mv	@@773@@(DE-627)822335905
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	TD1-1066
illustrated	Not Illustrated
issn	22998993
topic_title	TD1-1066 GE1-350 Impact of Pharmaceuticals on the Individual Wastewater Treatment System wastewater treatment small treatment plants activated sludge pharmaceuticals
topic	misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences
topic_unstemmed	misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences
topic_browse	misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Journal of Ecological Engineering
hierarchy_parent_id	822335905
hierarchy_top_title	Journal of Ecological Engineering
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)822335905 (DE-600)2818368-X
title	Impact of Pharmaceuticals on the Individual Wastewater Treatment System
ctrlnum	(DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483
title_full	Impact of Pharmaceuticals on the Individual Wastewater Treatment System
author_sort	Małgorzata Helena Makowska
journal	Journal of Ecological Engineering
journalStr	Journal of Ecological Engineering
callnumber-first-code	T
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2024
contenttype_str_mv	txt
container_start_page	257
author_browse	Małgorzata Helena Makowska Marcin Spychała Katarzyna Gajewska
container_volume	25
class	TD1-1066 GE1-350
format_se	Elektronische Aufsätze
author-letter	Małgorzata Helena Makowska
doi_str_mv	10.12911/22998993/176945
author2-role	verfasserin
title_sort	impact of pharmaceuticals on the individual wastewater treatment system
callnumber	TD1-1066
title_auth	Impact of Pharmaceuticals on the Individual Wastewater Treatment System
abstract	Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.
abstractGer	Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.
abstract_unstemmed	Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	2
title_short	Impact of Pharmaceuticals on the Individual Wastewater Treatment System
url	https://doi.org/10.12911/22998993/176945 https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html https://doaj.org/toc/2299-8993
remote_bool	true
author2	Marcin Spychała Katarzyna Gajewska
author2Str	Marcin Spychała Katarzyna Gajewska
ppnlink	822335905
callnumber-subject	TD - Environmental Technology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.12911/22998993/176945
callnumber-a	TD1-1066
up_date	2024-07-03T14:40:22.323Z
_version_	1803569198342864896
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ097958417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413201556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.12911/22998993/176945</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ097958417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TD1-1066</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">GE1-350</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Małgorzata Helena Makowska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of Pharmaceuticals on the Individual Wastewater Treatment System</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">wastewater treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">small treatment plants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">activated sludge</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pharmaceuticals</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental technology. Sanitary engineering</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental sciences</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marcin Spychała</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katarzyna Gajewska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Ecological Engineering</subfield><subfield code="d">Polish Society of Ecological Engineering (PTIE), 2014</subfield><subfield code="g">25(2024), 2, Seite 257-266</subfield><subfield code="w">(DE-627)822335905</subfield><subfield code="w">(DE-600)2818368-X</subfield><subfield code="x">22998993</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:257-266</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.12911/22998993/176945</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2299-8993</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2024</subfield><subfield code="e">2</subfield><subfield code="h">257-266</subfield></datafield></record></collection>
score	7.400649

Nicht das Richtige dabei?

Schreiben Sie uns!

Impact of Pharmaceuticals on the Individual Wastewater Treatment System

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?